302 results
Page 3 of 16
6-K
EX-99.1
y9atr1ykx5pbpov0t
8 May 23
Current report (foreign)
6:56am
6-K
EX-99.2
cbcuf2fsfpore 0s
8 May 23
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
6:53am
6-K
EX-99.1
axnpg foc1z
8 May 23
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
6:53am
6-K
EX-99.1
1rkcapja9ju6n7f p1
13 Apr 23
Invitation to the Annual General Meeting 2023
4:25pm
6-K
EX-99
dn3z g4cf7dt9o4
22 Dec 22
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
8:03am
6-K
EX-99.1
8iama 4m4
9 Dec 22
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation
9:17am
6-K
EX-99.1
ymz 9bgx1l9904oxv
8 Dec 22
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
5:27pm
6-K
EX-99.1
u7mwrn2c7hc4
5 Dec 22
Current report (foreign)
8:48am
6-K
EX-99.1
xu2lr8w r7vo
30 Nov 22
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates
7:51am
6-K
EX-99.1
vpts6z86 epbqnpdd7rt
18 Nov 22
Current report (foreign)
7:43am
6-K
EX-99.1
vj8ytjdpn2w bm5f3fep
16 Nov 22
Current report (foreign)
9:56pm
6-K
EX-99.1
bbpirl
10 Nov 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster
4:33pm
6-K
EX-99.1
mkegrn5ljusfsm7vrf
7 Nov 22
Unaudited Interim Condensed Consolidated Financial Statements
6:24am
6-K
EX-99.1
5a6i58oom0
7 Nov 22
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
6:07am
6-K
EX-99.2
m20lsjwcidwlx
7 Nov 22
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
6:07am
6-K
EX-99.1
kdpdedpzrjza
4 Nov 22
Current report (foreign)
5:00pm
20-F/A
bme4p25p
26 Oct 22
Annual report (foreign) (amended)
5:20pm
6-K
EX-99
qghqe zcqh
19 Oct 22
Current report (foreign)
6:27pm
6-K
EX-99.1
4f0 0r6wy3sp
13 Oct 22
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
5:58pm
6-K
EX-99.1
xk19uf8higan
12 Oct 22
Current report (foreign)
5:17pm